RETHINKDEPRESSION Trademark

Trademark Overview


On Thursday, May 25, 2017, a trademark application was filed for RETHINKDEPRESSION with the United States Patent and Trademark Office. The USPTO has given the RETHINKDEPRESSION trademark a serial number of 87463877. The federal status of this trademark filing is PARTIAL SECTION 8 ACCEPTED as of Tuesday, April 15, 2025. This trademark is owned by H. Lundbeck A/S. The RETHINKDEPRESSION trademark is filed in the Pharmaceutical Products, Education & Entertainment Services, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

[ Education services, namely, arranging and conducting seminars, conferences, symposiums, workshops and courses in the field of medical research and development, science, clinical studies, tests and trials, diagnostic, medicine, pharmaceuticals, disorders, diseases, treatment and prevention; educational and training services in the field of research and development relating to the treatment and prevention of central nervous system diseases and disorders; providing the aforementioned services electronically, on-line, via cable or Internet or other electronic media; arranging and conducting expert forums, including on-line in the form of seminars, conferences, symposiums, workshops and courses in the field of research and development relating to the treatment and prevention of central nervous system diseases and disorders; providing on-line training programs in the field of research and development relating to the treatment and prevention of central nervous system diseases and disorders...

[ Vaccines; pharmaceutical preparations and substances for the prevention and treatment of disorders and diseases in, generated by or acting on the central nervous system; central nervous system stimulants; pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological disorders and diseases; pharmaceutical preparations and substances for the prevention and treatment of dementia, Alzheimer's disease and disorder, dizziness, seizures, stroke, depression, cognitive impairment, cognitive disorders and diseases, mood disorders, psychosis, anxiety, apathy, epilepsy, Lennox-Gastaut syndrome (LGS), sclerosis, porphyria, Huntington's disease and disorder, insomnia, Parkinson's disease and disorder, falls, movement disorders and diseases, schizophrenia, bipolar disorder and disease, ADHD, oncology, pain, alcoholism and dependency; medical preparations, substances, reagents and diagnostic agents for medical purposes ]

[ Medical and therapeutic services relating to the treatment and prevention of brain and central nervous system diseases and disorders; healthcare services, namely, clinical healthcare; medical, clinical, therapeutic clinical services in the field of brain and central nervous system diseases and disorders; healthcare information services; medical services in the field of psychiatry and psychology and medical treatment of central nervous system related diseases and disorders; medical advice related to the treatment of central nervous system diseases and disorders; healthcare and medical services related to the treatment and prevention of central nervous system and brain diseases and disorders; ] providing medical and medicinal information in the field of diagnostics, medicine and pharmaceuticals for the treatment and prevention of diseases and disorders of the central nervous system; providing on-line medical information, namely, data and analyses designed to provide patients and cli...

[ Scientific and technological services, namely, research and design in the field of pharmaceuticals for the treatment and prevention of diseases and disorders of the central nervous system; medical and scientific research, namely, conducting clinical trials for others; clinical studies tests and trials; industrial analysis and research in the field of research and development relating to the treatment and prevention of diseases and disorders of the central nervous system; pharmaceutical research and development services; medical research; providing information in the field of research and development related to the treatment and prevention of central nervous system diseases and disorders ]
rethinkdepression

General Information


Serial Number87463877
Word MarkRETHINKDEPRESSION
Filing DateThursday, May 25, 2017
Status704 - PARTIAL SECTION 8 ACCEPTED
Status DateTuesday, April 15, 2025
Registration Number5604219
Registration DateTuesday, November 13, 2018
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, August 28, 2018

Trademark Statements


Goods and Services[ Education services, namely, arranging and conducting seminars, conferences, symposiums, workshops and courses in the field of medical research and development, science, clinical studies, tests and trials, diagnostic, medicine, pharmaceuticals, disorders, diseases, treatment and prevention; educational and training services in the field of research and development relating to the treatment and prevention of central nervous system diseases and disorders; providing the aforementioned services electronically, on-line, via cable or Internet or other electronic media; arranging and conducting expert forums, including on-line in the form of seminars, conferences, symposiums, workshops and courses in the field of research and development relating to the treatment and prevention of central nervous system diseases and disorders; providing on-line training programs in the field of research and development relating to the treatment and prevention of central nervous system diseases and disorders; providing on-line publications, namely, books, reports, brochures, booklets, leaflets, patient information leaflets, magazines, journals, teaching and educational material in the field of research and development relating to the treatment and prevention of central nervous system diseases and disorders ]
Description of MarkThe mark consists of the words "RETHINKDEPRESSION" with a thought cloud over the letter "I." The word "RETHINK" is in blue; the word "DEPRESSION" and the thought cloud are in red. The color white is not claimed as a feature of the mark and represents background.
Amendment to a Registration/Renewal CertificateThe drawing is amended to appear as follows: PUBLISH NEW CUT
Goods and Services[ Vaccines; pharmaceutical preparations and substances for the prevention and treatment of disorders and diseases in, generated by or acting on the central nervous system; central nervous system stimulants; pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological disorders and diseases; pharmaceutical preparations and substances for the prevention and treatment of dementia, Alzheimer's disease and disorder, dizziness, seizures, stroke, depression, cognitive impairment, cognitive disorders and diseases, mood disorders, psychosis, anxiety, apathy, epilepsy, Lennox-Gastaut syndrome (LGS), sclerosis, porphyria, Huntington's disease and disorder, insomnia, Parkinson's disease and disorder, falls, movement disorders and diseases, schizophrenia, bipolar disorder and disease, ADHD, oncology, pain, alcoholism and dependency; medical preparations, substances, reagents and diagnostic agents for medical purposes ]
Pseudo MarkRETHINK DEPRESSION
Indication of Colors claimedThe color(s) red and blue is/are claimed as a feature of the mark
Goods and Services[ Medical and therapeutic services relating to the treatment and prevention of brain and central nervous system diseases and disorders; healthcare services, namely, clinical healthcare; medical, clinical, therapeutic clinical services in the field of brain and central nervous system diseases and disorders; healthcare information services; medical services in the field of psychiatry and psychology and medical treatment of central nervous system related diseases and disorders; medical advice related to the treatment of central nervous system diseases and disorders; healthcare and medical services related to the treatment and prevention of central nervous system and brain diseases and disorders; ] providing medical and medicinal information in the field of diagnostics, medicine and pharmaceuticals for the treatment and prevention of diseases and disorders of the central nervous system; providing on-line medical information, namely, data and analyses designed to provide patients and clients with customized information regarding diagnosis and treatment
Goods and Services[ Scientific and technological services, namely, research and design in the field of pharmaceuticals for the treatment and prevention of diseases and disorders of the central nervous system; medical and scientific research, namely, conducting clinical trials for others; clinical studies tests and trials; industrial analysis and research in the field of research and development relating to the treatment and prevention of diseases and disorders of the central nervous system; pharmaceutical research and development services; medical research; providing information in the field of research and development related to the treatment and prevention of central nervous system diseases and disorders ]

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeB - Sec. 8 - Class(es) in a Multiple Class registration
Class Status DateTuesday, April 15, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class041 - Education; providing of training; entertainment; sporting and cultural activities.
US Class Codes100, 101, 107
Class Status CodeB - Sec. 8 - Class(es) in a Multiple Class registration
Class Status DateTuesday, April 15, 2025
Primary Code041
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status CodeB - Sec. 8 - Class(es) in a Multiple Class registration
Class Status DateTuesday, April 15, 2025
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, June 1, 2017
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameH. Lundbeck A/S
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressValby 2500
DK

Party NameH. Lundbeck A/S
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
Address2500 Valby
DK

Party NameH. Lundbeck A/S
Party Type10 - Original Applicant
Legal Entity Type99 - Other
Address2500 Valby
DK

Trademark Events


Event DateEvent Description
Monday, July 3, 2017ASSIGNED TO EXAMINER
Monday, May 29, 2017NEW APPLICATION ENTERED
Thursday, June 1, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, June 2, 2017NOTICE OF DESIGN SEARCH CODE E-MAILED
Monday, July 10, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, July 10, 2017NON-FINAL ACTION E-MAILED
Monday, July 10, 2017NON-FINAL ACTION WRITTEN
Tuesday, January 2, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, January 24, 2018NON-FINAL ACTION WRITTEN
Monday, July 16, 2018EXAMINERS AMENDMENT E-MAILED
Tuesday, January 2, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, January 3, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, January 24, 2018NON-FINAL ACTION E-MAILED
Wednesday, January 24, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, July 16, 2018EXAMINERS AMENDMENT -WRITTEN
Monday, July 16, 2018NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, August 8, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 13, 2018REGISTERED-PRINCIPAL REGISTER
Monday, July 16, 2018ASSIGNED TO LIE
Monday, July 16, 2018EXAMINER'S AMENDMENT ENTERED
Monday, July 16, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, July 20, 2018ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Monday, July 23, 2018ELECTRONIC RECORD REVIEW COMPLETE
Tuesday, August 28, 2018PUBLISHED FOR OPPOSITION
Tuesday, August 28, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Monday, November 13, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, March 22, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, March 22, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, March 22, 2024TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Friday, March 22, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, March 22, 2024TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
Friday, November 8, 2024TEAS SECTION 7 REQUEST RECEIVED
Friday, November 8, 2024TEAS SECTION 8 RECEIVED
Monday, April 7, 2025CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, April 15, 2025AMENDMENT UNDER SECTION 7 - PROCESSED
Tuesday, April 15, 2025REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED
Tuesday, April 15, 2025NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
Tuesday, May 6, 2025NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED